The Chris Stigall Show 6:00am - 9:00am

Listen Live

Search

Health Alert: Residents Warned Against Eating Eggs Near Chemical Facility

Wednesday, February 18, 2026 at 6:45 AM

People living near a chemical manufacturing facility in Lancashire have been told not to consume locally-produced eggs due to elevated levels of a substance that may cause cancer. The warning stems from an ongoing probe into past pollution at the industrial site.

Health officials have issued a cautionary advisory to people residing near a chemical manufacturing facility in Lancashire, England, urging them to stop consuming eggs produced in their local area.

The warning comes after testing revealed elevated concentrations of a substance with potential cancer-causing properties in locally-produced eggs. This discovery is connected to an ongoing investigation examining historical pollution from portions of what was once an ICI industrial site.

The facility is currently operated by AGC Chemicals Europe Ltd. Authorities are taking precautionary measures while they continue to assess the extent of contamination and its potential health impacts on the surrounding community.

Share

More from TV Delmarva Channel 33 News

  • Palestinians Mark Ramadan Among Destroyed Mosques in Gaza

    The Muslim holy month of Ramadan began Wednesday in Gaza as Palestinians gathered to pray in the debris of destroyed mosques and temporary shelters. Many worshippers mourned the loss of their sacred spaces while attempting to observe the religious period amid widespread destruction.

  • New Jersey Data Analytics Firm Verisk Exceeds Q4 Profit Expectations

    Verisk, a New Jersey-based insurance data analytics company, reported fourth-quarter earnings that surpassed Wall Street predictions, driving shares up nearly 10% in pre-market trading. The strong performance came despite challenges from reduced weather activity and a smaller federal contract.

  • Medical Device Company Exceeds Expectations with Insulin Pump Sales Growth

    Insulet Corporation surpassed Wall Street projections for the fourth quarter, driven by increased sales of its tubeless insulin delivery devices. The company reported a 31% revenue jump and announced plans for significant stock buybacks in 2026.

  • Drug Research Company Projects Strong 2026 Profits as Biotech Demand Rebounds

    Charles River Laboratories announced Wednesday it expects 2026 profits to exceed Wall Street predictions, citing recovering demand from biotechnology companies for drug research services. The Massachusetts-based contract research firm reported fourth-quarter earnings that beat analyst expectations despite some revenue challenges.